Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - COMMON STOCK REPURCHASED
Common Stock Repurchased URGN - UroGen Pharma Ltd.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR